1,151 research outputs found

    Criterios relevantes para la notificación de posibles donantes de córnea: una revisión integradora

    Get PDF
    Sintetizar a produção de conhecimento referente aos fatores clínicos e sociológicos necessários para otimizar o processo de notificação de potenciais doadores de córnea. Métodos: Trata-se de uma revisão integrativa, a partir da pergunta norteadora: “quais os critérios clínicos e sociodemográficos necessários para eficaz notificação de potenciais doadores de córnea?” Para seleção dos artigos, utilizou-se seis bases de dados eletrônicas na área da saúde com período entre 2010 e 2022, nos idiomas português e inglês. Resultados: Dos 1.266 estudos inicialmente obtidos, excluiu-se 1.266 durante as filtragens, resultando em uma amostra final de 15 estudos. A análise viabilizou as seguintes categorizações: características sociodemográficas e clínicas dos pacientes; causas da não efetivação da doação de córneas; estratégias para aperfeiçoar o processo de doação de córnea. Considerações finais: Os resultados ofereceram critérios norteadores capazes de amparar à construção de documentos para auxílio da efetiva notificação de potenciais doadores de córnea.Objective: To synthesize the production of knowledge regarding the clinical and sociological factors necessary to optimize the notification process of potential corneal donors. Methods: An integrative review was used, based on the guiding question: "What are the clinical and sociodemographic criteria necessary for effective notification of potential corneal donors?" For the selection of articles, six electronic databases in the health area published between 2010 and 2022, in Portuguese and English, were used. Results: Of the 1,266 studies initially obtained, 1,266 were excluded during filtering, resulting in a final sample of 15 studies. The analysis enabled the following categorizations: sociodemographic and clinical characteristics of the patients; causes for non-completion of corneal donation; Strategies to improve the corneal donation process. Final considerations: The results offered guiding criteria capable of supporting the construction of documents to aid in the effective notification of potential corneal donors.Objetivo: Sintetizar la producción de conocimiento sobre los factores clínicos y sociológicos necesarios para optimizar el proceso de notificación de potenciales donantes de córnea. Métodos: Se utilizó una revisión integradora, basada en la pregunta orientadora: "¿Cuáles son los criterios clínicos y sociodemográficos necesarios para la notificación efectiva de potenciales donantes de córnea?" Para la selección de artículos, se utilizaron seis bases de datos electrónicas del área de la salud publicadas entre 2010 y 2022, en portugués e inglés. Resultados: De los 1266 estudios obtenidos inicialmente, 1266 fueron excluidos durante el filtrado, resultando una muestra final de 15 estudios. El análisis permitió las siguientes categorizaciones: características sociodemográficas y clínicas de los pacientes; causas de no finalización de la donación de córnea; Estrategias para mejorar el proceso de donación de córnea. Consideraciones finales: Los resultados ofrecieron criterios orientadores capaces de apoyar la construcción de documentos para auxiliar en la notificación efectiva de potenciales donantes de córnea

    Measurement of the cosmic ray spectrum above 4×10184{\times}10^{18} eV using inclined events detected with the Pierre Auger Observatory

    Full text link
    A measurement of the cosmic-ray spectrum for energies exceeding 4×10184{\times}10^{18} eV is presented, which is based on the analysis of showers with zenith angles greater than 6060^{\circ} detected with the Pierre Auger Observatory between 1 January 2004 and 31 December 2013. The measured spectrum confirms a flux suppression at the highest energies. Above 5.3×10185.3{\times}10^{18} eV, the "ankle", the flux can be described by a power law EγE^{-\gamma} with index γ=2.70±0.02(stat)±0.1(sys)\gamma=2.70 \pm 0.02 \,\text{(stat)} \pm 0.1\,\text{(sys)} followed by a smooth suppression region. For the energy (EsE_\text{s}) at which the spectral flux has fallen to one-half of its extrapolated value in the absence of suppression, we find Es=(5.12±0.25(stat)1.2+1.0(sys))×1019E_\text{s}=(5.12\pm0.25\,\text{(stat)}^{+1.0}_{-1.2}\,\text{(sys)}){\times}10^{19} eV.Comment: Replaced with published version. Added journal reference and DO

    Energy Estimation of Cosmic Rays with the Engineering Radio Array of the Pierre Auger Observatory

    Full text link
    The Auger Engineering Radio Array (AERA) is part of the Pierre Auger Observatory and is used to detect the radio emission of cosmic-ray air showers. These observations are compared to the data of the surface detector stations of the Observatory, which provide well-calibrated information on the cosmic-ray energies and arrival directions. The response of the radio stations in the 30 to 80 MHz regime has been thoroughly calibrated to enable the reconstruction of the incoming electric field. For the latter, the energy deposit per area is determined from the radio pulses at each observer position and is interpolated using a two-dimensional function that takes into account signal asymmetries due to interference between the geomagnetic and charge-excess emission components. The spatial integral over the signal distribution gives a direct measurement of the energy transferred from the primary cosmic ray into radio emission in the AERA frequency range. We measure 15.8 MeV of radiation energy for a 1 EeV air shower arriving perpendicularly to the geomagnetic field. This radiation energy -- corrected for geometrical effects -- is used as a cosmic-ray energy estimator. Performing an absolute energy calibration against the surface-detector information, we observe that this radio-energy estimator scales quadratically with the cosmic-ray energy as expected for coherent emission. We find an energy resolution of the radio reconstruction of 22% for the data set and 17% for a high-quality subset containing only events with at least five radio stations with signal.Comment: Replaced with published version. Added journal reference and DO

    Measurement of the Radiation Energy in the Radio Signal of Extensive Air Showers as a Universal Estimator of Cosmic-Ray Energy

    Full text link
    We measure the energy emitted by extensive air showers in the form of radio emission in the frequency range from 30 to 80 MHz. Exploiting the accurate energy scale of the Pierre Auger Observatory, we obtain a radiation energy of 15.8 \pm 0.7 (stat) \pm 6.7 (sys) MeV for cosmic rays with an energy of 1 EeV arriving perpendicularly to a geomagnetic field of 0.24 G, scaling quadratically with the cosmic-ray energy. A comparison with predictions from state-of-the-art first-principle calculations shows agreement with our measurement. The radiation energy provides direct access to the calorimetric energy in the electromagnetic cascade of extensive air showers. Comparison with our result thus allows the direct calibration of any cosmic-ray radio detector against the well-established energy scale of the Pierre Auger Observatory.Comment: Replaced with published version. Added journal reference and DOI. Supplemental material in the ancillary file

    Matsigenka

    Get PDF
    Está concebido como un texto de referencia para el uso adecuado de las grafías del alfabeto oficial en cada una del Matsigenka. El contenido, esquema final y título fue elaborado de manera participativa con estudiantes, dirigentes, representantes de las organizaciones indígenas de los pueblos involucrados, sabios y sabias de las comunidades y especialistas de educación intercultural bilingüe —todos ellos hablantes de su lengua y conocedores de su cultura—, y con el asesoramiento de lingüistas y educadores en distintos talleres organizados por la DIGEIBIR. Lo señalado ha permitido que cada texto refleje aquellos aspectos de mayor interés e importancia. El objetivo de este material es ayudar a lograr utilizar adecuadamente el alfabeto oficial de tu lengua, y puedas producir y comprender textos escritos con él, respetando las variedades dialectales

    Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study

    Get PDF
    Background: Patients on hemodialysis are at high-risk for complications derived from coronavirus disease 2019 (COVID-19). The present analysis evaluated the impact of a booster vaccine dose and breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on humoral immunity 3 months after the booster dose. Methods: This is a multicentric and prospective study assessing immunoglobulin G anti-Spike antibodies 6 and 9 months after initial SARS-CoV-2 vaccination in patients on hemodialysis that had also received a booster dose before the 6-month assessment (early booster) or between the 6- and 9-month assessments (late booster). The impact of breakthrough infections, type of vaccine, time from the booster and clinical variables were assessed. Results: A total of 711 patients [67% male, median age (range) 67 (20-89) years] were included. Of these, 545 (77%) received an early booster and the rest a late booster. At 6 months, 64 (9%) patients had negative anti-Spike antibody titers (3% of early booster and 29% of late booster patients, P =. 001). At 9 months, 91% of patients with 6-month negative response had seroconverted and there were no differences in residual prevalence of negative humoral response between early and late booster patients (0.9% vs 0.6%, P =. 693). During follow-up, 35 patients (5%) developed breakthrough SARS-CoV-2 infection. Antibody titers at 9 months were independently associated with mRNA-1273 booster (P =. 001), lower time from booster (P =. 043) and past breakthrough SARS-CoV-2 infection (P <. 001). Conclusions: In hemodialysis patients, higher titers of anti-Spike antibodies at 9 months were associated with mRNA-1273 booster, lower time from booster and past breakthrough SARS-CoV-2 infectionThe present project has been supported by Fresenius Medical Care, Diaverum, Vifor Pharma, Vircell, Fundación Renal Iñigo Álvarez de Toledo and ISCIII FEDER funds RICORS2040 (RD21/0005

    Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

    Full text link
    The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

    Novel genes and sex differences in COVID-19 severity

    Get PDF
    [EN] Here, we describe the results of a genome-wide study conducted in 11 939 coronavirus disease 2019 (COVID-19) positive cases with an extensive clinical information that were recruited from 34 hospitals across Spain (SCOURGE consortium). In sex-disaggregated genome-wide association studies for COVID-19 hospitalization, genome-wide significance (P < 5 × 10−8) was crossed for variants in 3p21.31 and 21q22.11 loci only among males (P = 1.3 × 10−22 and P = 8.1 × 10−12, respectively), and for variants in 9q21.32 near TLE1 only among females (P = 4.4 × 10−8). In a second phase, results were combined with an independent Spanish cohort (1598 COVID-19 cases and 1068 population controls), revealing in the overall analysis two novel risk loci in 9p13.3 and 19q13.12, with fine-mapping prioritized variants functionally associated with AQP3 (P = 2.7 × 10−8) and ARHGAP33 (P = 1.3 × 10−8), respectively. The meta-analysis of both phases with four European studies stratified by sex from the Host Genetics Initiative (HGI) confirmed the association of the 3p21.31 and 21q22.11 loci predominantly in males and replicated a recently reported variant in 11p13 (ELF5, P = 4.1 × 10−8). Six of the COVID-19 HGI discovered loci were replicated and an HGI-based genetic risk score predicted the severity strata in SCOURGE. We also found more SNP-heritability and larger heritability differences by age (<60 or ≥60 years) among males than among females. Parallel genome-wide screening of inbreeding depression in SCOURGE also showed an effect of homozygosity in COVID-19 hospitalization and severity and this effect was stronger among older males. In summary, new candidate genes for COVID-19 severity and evidence supporting genetic disparities among sexes are provided.S
    corecore